most effective glp-1 for obesity treatment 2025 Agonists Market Report 2025-2033, By Product, Molecule, and Geo BMI and GLP-1 Weight Loss

They slow gastric emptying, meaning food remains in the stomach longer, promoting feelings of fullness

PMID: 27321206

Glucagon-like peptide-1 receptor agonists are medications that mimic the action of the natural hormone GLP-1, which is released from the gut after eating

Additionally, we have identified critical knowledge gaps that require future research, including the definition of long-term therapy outcomes, understanding impacts on development and psychosocial well-being, and determining optimal combination therapies

& Guo, H

Segmentation Analysis By Product Ozempic (semaglutide) emerged as the dominant product in the GLP-1 Receptor Agonist market in 2025 holding a share of 35.12% owing to high efficacy, well-established prescribing trends, and clinical studies proving positive cardiovascular outcomes